Krabbe Disease Global Patient Registry
This study is creating a database of people with Krabbe disease to better understand how the disease develops and progresses. Researchers want to identify early symptoms, see if enzyme activity levels or specific genetic changes can predict the disease's course, and determine which brain tests can predict when symptoms will start or how severe they will be. This information is crucial because the only treatment for Krabbe disease is bone marrow transplantation, and it's important to identify factors that can accurately predict how the disease will unfold. You can participate if you have Krabbe disease, are at risk for it, or are a family member of someone with or at risk for Krabbe disease. The study aims to enroll 60 participants and will track overall survival for up to 5 years.
- Study design
- This is an observational study, meaning researchers will collect information without giving any specific treatments. It aims to enroll 60 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants' overall survival will be measured for up to 5 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Krabbe Disease Global Patient Registry
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Thomas J. Langan, MD · PRINCIPAL_INVESTIGATOR · Clinical Director, Clinical Research, Institute for Myelin and Glial Exploration
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Overall Survivalup to 5 years
The longevity of participants will be recorded using their date of death, or conclusion of this study, whichever occurs first.